Transcranial magnetic stimulation of visual cortex in migraine patients: a systematic review with meta-analysis
The Journal of Headache and Pain,

Brigo F et al. – Skull thickness and ovarian cycle should be assessed as possible confounding variables, and sham stimulation should be performed to reduce the rate of false positives. Phosphene prevalence alone cannot be considered a measure of cortical excitability, but should be integrated with phosphene threshold (PT) evaluation.

Methods
  • Authors systematically reviewed the literature to evaluate the prevalence of phosphenes and the phosphene threshold (PT) values obtained during single–pulse transcranial magnetic stimulation (TMS) in adults with migraine.
  • Controlled studies measuring PT by single–pulse TMS in adults with migraine with or without aura (MA, MwA) were systematically searched.
  • Prevalence of phosphenes and PT values were assessed calculating mean difference (MD) and odds ratio (OR) with 95 % confidence intervals (CI).
  • Ten trials (277 migraine patients and 193 controls) were included.
  • Patients with MA had statistically significant lower PT compared with controls when a circular coil was used (MD –28.33; 95 % CI –36.09 to –20.58); a similar result was found in MwA patients (MD –17.12; 95 % CI –23.81 to –10.43); using a figure–of–eight coil the difference was not statistically significant.
  • There was a significantly higher phosphene prevalence in MA patients compared with control subjects (OR 4.21; 95 % CI 1.18–15.01).
  • No significant differences were found either in phosphene reporting between patients with MwA and controls, or in PT values obtained with a figure–of–eight coil in MA and MwA patients versus controls.
  • Overall considered, these results support the hypothesis of a primary visual cortex hyper–excitability in MA, providing not enough evidence for MwA.
  • A significant statistical heterogeneity reflects clinical and methodological differences across studies, and higher temporal variabilities among PT measurements over time, related to unstable excitability levels.
  • Patients should therefore be evaluated in the true interictal period with an adequate headache–free interval.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...

Your Unread Messages in Internal Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Internal Medicine Articles

1 An avocado a day may help keep bad cholesterol at bay American Heart Association News, January 8, 2015

2 Breakthrough on chronic pain Harvard Gazette - Health News, January 13, 2015

3 E-readers foil good night's sleep Harvard Medical School News, December 24, 2014

4 Acupuncture for chronic knee pain: a randomized clinical trial JAMA, October 1, 2014    Evidence Based Medicine    Clinical Article

5 Resveratrol levels and all-cause mortality in older community-dwelling adults JAMA Internal Medicine, May 13, 2014    Evidence Based Medicine    Clinical Article

6 Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial The Lancet, January 26, 2015    Evidence Based Medicine    Clinical Article

7 Vitamin D and Calcium Supplementation to Prevent Fractures in Adults: U.S. Preventive Services Task Force Recommendation Statement Full Text Annals of Internal Medicine, February 26, 2013    Free full text    Clinical Guideline

8 Effects of tea intake on blood pressure: A meta-analysis of 21 randomized controlled trials JACC - Journal of the American College of Cardiology, October 22, 2014    Clinical Article

9 Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis Annals of Internal Medicine, January 19, 2015    Evidence Based Medicine    Review Article    Clinical Article

10 Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174000 participants in 27 randomised trials The Lancet, January 14, 2015    Evidence Based Medicine    Clinical Article

11 Elevated circulating microrna-122 is associated with obesity and insulin resistance in young adults European Journal of Endocrinology, December 19, 2014    Clinical Article

12 Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial The Lancet, December 19, 2014    Evidence Based Medicine    Clinical Article

13 Initial management of Parkinson's disease BMJ, January 20, 2015    Review Article    Clinical Article

14 Plasma levels of MASP-1 and MASP-2 are elevated in type 1 diabetes and correlate with glycemic control Clinical and Experimental Immunology, January 9, 2015    Clinical Article

15 Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis Annals of Internal Medicine, December 24, 2014    Evidence Based Medicine    Clinical Article

16 Calcium and phosphorus intake and prostate cancer risk: A 24-y follow-up study American Journal of Clinical Nutrition, November 26, 2014    Clinical Article

17 Spironolactone for heart failure with preserved ejection fraction Full Text New England Journal of Medicine, April 11, 2014    Free full text    Evidence Based Medicine    Clinical Article

18 Tea consumption and leukemia risk: A meta-analysis Tumor Biology, February 12, 2014    Evidence Based Medicine    Clinical Article

19 Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: The GIPS-III randomized clinical trial Full Text JAMA, April 16, 2014    Free full text    Evidence Based Medicine    Clinical Article

20 Severe Ebola virus disease with vascular leakage and multiorgan failure: Treatment of a patient in intensive care The Lancet, January 7, 2015    Evidence Based Medicine    Clinical Article

Indexed Journals in Internal Medicine: New England Journal of Medicine, The Lancet, Archives of Internal Medicinemore

Looking for a physician job? Let us help!

Register now for our free job placement service.
A career consultant will contact you soon.
Click Here for more information.

Get Started Now!

Free-of-charge, no obligation.

Terms and Conditions For M3 Career Consult

By registering with the M3 Career Consult service you authorize M3 USA Corporation to represent you in your job search. The following is a summary of the terms of our service and our mutual obligations to help you find a job:

  • You designate M3 to act as your agent and represent you in your job search;
  • You will not pay us for this service
  • You will advise us of any companies or positions to which you apply or have applied;
  • You will advise us if you believe you are not capable of performing a position for which we submit you, or for which you interview;
  • You will keep all information we provide you about companies or positions strictly confidential;
  • You will promptly provide us with information we request of you;
  • You will make yourself reasonably available for phone, video and in-person conversations and interviews;
  • You will be truthful in all of your communications with us; and
  • You will advise us if anything above changes.
 

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List